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Introduction
Excessive blood coagulation results in the formation of
thrombi. The main components of thrombi are cells such
as platelets and erythrocytes and a ﬁbrin network that is
essential for the structural stability of the thrombus.1 Fibrin-
ogen circulates at a plasma concentration of approximately
2.5 mg/mL (normal range 1.5–4.0 mg/mL). When blood co-
agulation is activated and thrombin is generated, ﬁbrinogen
is converted to ﬁbrin monomers, which polymerize into
protoﬁbrils. These protoﬁbrils aggregate laterally into ﬁbers,
which ﬁnally form the three-dimensional ﬁbrin network of
thrombi or of ﬁbrin clots when plasma is clotted in vitro.1
Activated coagulation factor XIII (FXIIIa) is a transgluta-
minase that introduces several cross-links into the ﬁbrin
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Abstract Background Many proteins bind to ﬁbrin during clot formation in plasma. We
previously identiﬁed by mass spectrometry the most abundant proteins that non-
covalently bind to ﬁbrin clots. Several of these proteins (e.g., apolipoprotein J/clusterin,
haptoglobin, α2-macroglobulin, α1-antitrypsin) can act as extracellular chaperones.
Objective We hypothesize that clot-binding proteins may interact with ﬁbrin as
chaperones. The goal of this study is to test this hypothesis and to investigate the origin
of the cross-β or amyloid structures in ﬁbrin clots, which are associated with protein
unfolding.
Methods and Results A thioﬂavin T assay was used to detect cross-β structures. A
steadily increasing amount was measured in the ﬁbrinogen fraction of plasma during
heat stress, a standard treatment to induce unfolding of proteins. Heat-stressed plasma
was clotted and clot-bound proteins were analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The results showed that the amounts of the
clot-bound proteins were related to the duration of the heat stress. This indicates that
cross-β structures in unfolded ﬁbrin(ogen) are involved in clot binding of the proteins,
which supports our chaperone hypothesis. A contributing role of ﬁbrin formation itself
was studied by clotting puriﬁed ﬁbrinogen with thrombin in the presence of thioﬂavin
T. The ﬂuorescence intensity increased in time in the presence of thrombin, but did not
increase in its absence. This provides evidence for the generation of cross-β structures
during ﬁbrin formation.
Conclusion Fibrin clots generated in plasma are decorated with extracellular chap-
erones. The binding of these chaperones involves cross-β structures originating both
from unfolded ﬁbrinogen and from ﬁbrin formation.
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network, thereby stabilizing the clot.2 The action of FXIIIa
also results in resistance to ﬁbrinolysis.3 This is accom-
plished not only by intramolecular cross-links within ﬁbrin,
but also by intermolecular cross-links between ﬁbrin and the
ﬁbrinolysis inhibitor α2-antiplasmin. FXIIIa is able to cova-
lently cross-link many different plasma proteins to ﬁbrin. A
recent proteomic study identiﬁed 48 plasma proteins that
are cross-linked to ﬁbrin clots by FXIIIa.4
Plasma clots not only contain FXIIIa-mediated covalently
bound plasma proteins, but also noncovalently bound pro-
teins. The binding of these proteins may be involved in the
regulation of hemostasis.5 Well-known examples are the
binding of thrombin which limits thrombus formation6
and the binding of both plasminogen and tissue-type plas-
minogen activator (tPA) which strongly accelerates plasmin
formation and thereby ﬁbrinolysis.7 By using the proteomic
analysis of washed plasma clots, we previously identiﬁed 18
abundant noncovalently clot-bound proteins.8Using a slight-
ly different approach, other investigators did not distinguish
covalently and noncovalently clot-bound proteins and stud-
ied the whole clot proteome.9–11 The 18 noncovalently
bound proteins that we identiﬁed, included several hemo-
static proteins. However, the background of the binding of
the majority of the noncovalently bound proteins in a clot
remains unknown and this forms the main topic of the
present study. We report that a signiﬁcant number of these
proteins are described in the literature as extracellular
chaperones, a family of proteins in the extracellular ﬂuids
that share functional characteristics with intracellular chap-
erones.12We provide evidence that they might be present in
a ﬁbrin clot on the basis of their chaperone activity. Chap-
erones bind to partially unfolded proteins, which may form
cross-β or amyloid-like protein structures. We studied the
origin of these structures in the ﬁbrin clot.
Materials and Methods
Materials
Human thrombin, urea, thiourea, and CHAPS were obtained
from Sigma (St. Louis, Missouri, United States). Bovine milk
α-, β-, and κ-casein were also obtained from Sigma (product
number C6780, C6905, and C0406, respectively). Aprotinin
was obtained from BioVision (Milpitas, California, United
States) and puriﬁed human ﬁbrinogen (plasminogen-, von
Willebrand factor-, and ﬁbronectin-depleted) from Enzyme
Research Laboratories (South Bend, Indiana, United States).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE)was calibratedwith Precision Plus Protein Stand-
ards from Bio-Rad Laboratories (Hercules, California, United
States). GelCode Blue Stain Reagent was from Thermo Scien-
tiﬁc (Waltham, Massachusetts, United States) and Thioﬂavin
T UltraPure Grade (ThT) from AnaSpec (Fremont, California,
United States). The antibodies used for the α1-antitrypsin
(A1AT)-ﬁbrinogen enzyme-linked immunosorbent assay
(ELISA) were from Afﬁnity Biologicals (Ancaster, Ontario,
Canada). Plasma was normal pooled platelet-poor plasma,
prepared from citrated apheresis plasma (Sanquin blood
bank, Rotterdam, The Netherlands) from ﬁve healthy donors.
Heat-Induced Unfolding of Fibrinogen in Plasma
Plasma was supplemented with sodium azide (0.05% ﬁnal
concentration) and incubated in 1 mL aliquots for 0, 1, or
2 days at 37° or 41°C. Fibrinogen was isolated by two
successive ammonium sulfate precipitations at 25% satura-
tion and dissolved in 5 mM sodium citrate.13 Unfolding of
ﬁbrinogen during the incubations at 37°C or 41°C resulting in
cross-β structures was assessed by mixing ﬁbrinogen and
ThT (1 mg/mL and 0.1 mM ﬁnal concentrations, respective-
ly) in 5 mM sodium citrate. ThT ﬂuorescence of 100 μL
aliquots was measured in black microtiter plates using a
Victor3 plate reader (PerkinElmer, Waltman, Massachusetts,
United States) with excitation at 425 nm and emission at
486 nm and expressed in arbitrary units (a.u.). All measure-
ments were done at 20°C for 0.1 second at a continuouswave
lamp intensity of 10,000.
Clot-Bound Proteins after Heat Treatment of Plasma
Plasma was supplemented with sodium azide (0.05% ﬁnal
concentration) and incubated for 0, 1, or 2 days at 41°C. Next,
calcium chloride (20 mM ﬁnal concentration), thrombin
(1 NIH U/mL ﬁnal concentration), and aprotinin (100 KIU/
mL ﬁnal concentration) were added to each plasma sample
(500 µL) to induce clot formation.8 After 2 hours of incuba-
tion at room temperature, the clots were extensively washed
by perfusing them overnight with 10 mLTris-buffered saline
(50 mMTris-HCl, 100 mMNaCl, pH 7.4) containing aprotinin
(100 KIU/mL) at 4°C. The clots were compacted by centrifu-
gation, washed with deionized water, and noncovalently
clot-bound proteins were extracted with 30 µL rehydration
buffer (7 Murea, 2 M thiourea, 4% [w/v] CHAPS) for 1 hour at
room temperature. The extracts were mixed with SDS-PAGE
sample buffer containing β-mercaptoethanol, incubated for
5 minutes at 95°C and analyzed using SDS-PAGE (Laemmli
system, 12% gel). Proteins were stained using GelCode Blue
Stain Reagent according to the manufacturer’s instructions.
The proteins in the main bands were identiﬁed by matrix-
assisted laser desorption/ionization time-of-ﬂight (MALDI-
ToF), as described previously.8
Heat-Induced Formation of A1AT–Fibrinogen Complex
in Plasma
Plasma was supplemented with sodium azide (0.05% ﬁnal
concentration) and incubated in 1 mL aliquots for 0, 0.25, 1,
or 2 days at 37°C or 41°C. Fibrinogen was isolated by two
successive ammonium sulfate precipitations at 25% saturation
and dissolved in 5 mM sodium citrate.13 A1AT–ﬁbrinogen
complex concentration in the ﬁbrinogen samples was deter-
minedusing a sandwich ELISA consistingof a capture antibody
against A1AT and a horseradish peroxidase-labeled detecting
antibody against ﬁbrinogen, as described previously.14
Generation of Cross-β Structures during Coagulation
Generation of cross-β structures during coagulationwas tested
by incubating 3 mg/mL commercially available ﬁbrinogen in
black microtiter plates (150 μL/well) with 7.5 mM calcium
chloride and 0.25 NIH U/mL human thrombin in 50 mM Tris-
HCl, pH8.0 containing100 mMNaCl, in thepresenceof0.1 mM
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ThT. Fluorescence in the samples was measured as described
above, both before and repeatedly after the induction of
coagulation with thrombin for 60 minutes at 20°C. Fibrinogen
samples without added thrombin were measured as control.
Clot formation of similar samples was measured as turbidity
(optical density [OD] at 405 nm) in parallel experiments.
Effect of Casein Proteins on Fibrin Polymerization
The effects of the extracellular chaperones α-, β-, and κ-casein
on ﬁbrin polymerization were tested in microtiter plates as
described by Carter et al15 with slight modiﬁcations: 100 µL
diluted plasmawith α-, β-, or κ-casein in assay buffer (50 mM
Tris-HCl, pH7.4, containing 100 mMNaCl and1 mg/mLbovine
serum albumin) was mixed in duplicate with 50 µL thrombin
and calcium chloride in assay buffer and covered with 50 µL
parafﬁn oil. Clot formation was monitored by measuring the
OD at 405 nm every 35 seconds for 60 minutes at room
temperature in a microplate reader. The ﬁnal concentrations
in the clotwere11.1% (v/v)plasma,0, 5, 10, 20, or30 µMcasein
protein, 0.001 NIH U/mL thrombin, and 2.5 mMcalcium chlo-
ride. This corresponds to amolar ratio of casein andﬁbrinogen
of approximately 0, 5, 10, 20, or 30, respectively.
Results
When plasma is clotted, several proteins are noncovalently
bound to the ﬁbrin clot matrix. ►Fig. 1 shows two-dimen-
sional (2D)gel electrophoresis of theseproteins, alongwith the
identiﬁcation of the most abundant ones, as we published
previously.8 The proteins identiﬁed show up as ladders or row
of spots,which is commonforplasmaproteins. Thepresenceof
these proteins in a ﬁbrin clot, apart from the presence of the
ﬁbrin-binding hemostatic proteins plasminogen, FXIII-A sub-
unit, thrombin, and possibly carboxypeptidase N (CPN), is not
well understood. However,►Fig. 1 shows that the majority of
the apparently nonhemostatic ﬁbrin clot-bound proteins con-
sists of proteins that are classiﬁed byWyatt et al12 as extracel-
lular chaperones or at least as extracellular proteins with
chaperone activity (white printed protein names).These pro-
teins include apolipoprotein J (ApoJ), also known as clusterin,
haptoglobin, α2-macroglobulin (α2M), ApoE, ApoAI, albumin,
serum amyloid P, and A1AT.
Extracellular chaperones bind to unfolded proteins, which
can aggregate into soluble oligomers and subsequently into
amorphous material or into ﬁbrillary material both contain-
ing cross-β structures.12 To test our hypothesis that the
nonhemostatic clot-bound proteins bind to a ﬁbrin clot
because of their chaperone activities, plasma was incubated
at elevated temperature to increase the content of unfolded
ﬁbrinogen, after which the plasma was clotted and clots
were analyzed for the presence of clot-bound proteins. In
pilot experiments, plasmawas incubated at varying temper-
atures, ﬁbrinogen was isolated, and unfolding of ﬁbrinogen
was assessed with ThT, a fairly speciﬁc reagent for cross-β
structures.16,17 ►Fig. 2 shows that ﬁbrinogen isolated from
control plasma (incubation time: 0 days) produced already a
signiﬁcant ThT ﬂuorescence intensity of approximately
1,400 a.u. pointing to the presence of unfolded ﬁbrinogen
in the startingmaterial. Incubation of plasma for 2 days at 37°
C hardly increased the ThT ﬂuorescence. However, incuba-
tion of plasma at 41°C resulted in a steadily increasing ThT
ﬂuorescence, indicating a steadily increasing amount of
unfolded ﬁbrinogen. Incubation of plasma at 45°C resulted
in an even higher ﬂuorescence, but some protein precipita-
tion occurred in these samples.
Therefore, a temperature of 41°C was selected and plasma
was incubated for 0, 1, or 2 days and clottedwith calcium and
thrombin. Clots were extensively washed and clot-bound
proteins were extracted and analyzed by SDS-PAGE. One-
dimensional SDS-PAGE was chosen rather than 2D electro-
phoresis used in ►Fig. 1 to allow a better comparison of the
amounts of clot-bound proteins after varying incubation
periods of the plasma (►Fig. 3). The clot prepared from
plasma incubated for 0 days provided a protein sample that
was similar to the protein sample analyzed by 2D gel
electrophoresis in ►Fig. 1. Indeed, the protein bands
Fig. 1 Plasma-clot bound proteins after separation with two-dimensional (2D) gel electrophoresis and identiﬁcation by mass spectrometry. The
ﬁgure is adapted from Talens et al, 2012.8 The majority of the proteins, indicated in white, are described as having chaperone activity.12
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in►Fig. 3 (0 days incubation) matched well with the protein
spots in ►Fig. 1. The clots prepared from plasma incubated
for 1 or 2 days yielded the same protein bands as the clot
prepared from nonincubated plasma but with a gradually
increasing intensity. This result strongly suggests that un-
folded ﬁbrin(ogen) is involved in the binding of the proteins,
both before and after the incubation of plasma at 41°C, which
supports our chaperone hypothesis.
The identity of the protein bands in ►Fig. 3 was partially
derived from MALDI-ToF analysis and partially by comparing
the migration of the bands with the vertical migration of the
spots, shown in►Fig. 1 (►Table 1). Inmost bands extracellular
chaperones were identiﬁed, except in band 1 (ﬁbronectin),
band4 (plasminogen), band5 (CPN, polypeptide2), andband6
(FXIII-A). The intensity of the latter bands also increased with
the incubation time of plasma. This may suggest that the
binding of these proteins to ﬁbrinmight also involve unfolded
ﬁbrin(ogen)/cross-β structures in the ﬁbrin network.
The results of the experiment shown in►Fig. 3 suggest that
the chaperone proteins bind to unfolded ﬁbrinogen and
remain associated during ﬁbrin formation. The binding of
the most abundant clot-binding protein A1AT14 to unfolded
ﬁbrinogen was also assessed in plasma (without clot forma-
tion) with an ELISA speciﬁcally detecting A1AT–ﬁbrinogen
complexes. ►Fig. 4 shows that nonincubated plasma con-
tained approximately 4 μg/mL A1AT–ﬁbrinogen complex,
which is in line with our previous work.14 This concentration
hardly increased during the incubation of plasma for 2 days at
37°C. The complex concentration increased strongly during
incubationat41°C, in linewith a signiﬁcant rateof unfoldingof
Fig. 3 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) of clot-bound proteins after heat treatment of plasma.
Platelet-poor citrated plasma was incubated for 0, 1, or 2 days at 41°C
and clots were prepared by adding calcium chloride, thrombin, and
aprotinin. Unbound proteins were washed away, bound proteins were
extracted, analyzed using SDS-PAGE, and stained with GelCode Blue
Stain Reagent. The left lane shows the protein markers. The identity of
the individual protein bands 1–12 in the other three lanes is shown in
►Table 1.
Fig. 2 Heat-induced unfolding of ﬁbrinogen in plasma. Platelet-poor
citrated plasma was stressed by incubation at 37°C or 41°C for 0, 1, or
2 days. After the incubation ﬁbrinogen was isolated from the plasma
samples by ammonium sulfate precipitation. Cross-β structures in the
ﬁbrinogen samples were measured by thioﬂavin T (ThT) ﬂuorescence.
The background of the ThT signal (2,023 arbitrary units [a.u.]) was
subtracted from all samples. Mean values (with range) of duplicate
measurements are shown; the error bars are in some cases too small
to be visible.
Table 1 Identity of protein bands of SDS-PAGE of clot-bound
proteins, shown in ►Fig. 3
Band no. Protein
1 Fibronectin
2 α2-Macroglobulin
3 α2-Macroglobulin
4 Plasminogen
5 Carboxypeptidase N, polypeptide 2
6 Coagulation factor XIII, A1 polypeptide
7 Albumin
8 α1-Antitrypsin
9 Actin, gamma 1
Apolipoprotein AIV
Haptoglobin
10 Apolipoprotein J (clusterin)
α1-Antitrypsin
11 Apolipoprotein E
HFREP-1
12 Apolipoprotein AI
Immunoglobulin light chain
Serum amyloid P
Abbreviations: HFREP-1, hepatocyte-derived ﬁbrinogen-related protein-
1; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis.
Note: The proteins labeled with a star were identiﬁed by matrix-assisted
laser desorption/ionization time-of-ﬂight (MALDI-ToF). The other pro-
teins were identiﬁed by comparing the migration of the bands with the
vertical migration of the spots, shown in ►Fig. 1.
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ﬁbrinogen at 41°C, as observed in ►Fig. 2. This experiment
indicates that clotting is not required for the formation of a
complex between a chaperone and ﬁbrin(ogen).
Although clot formation is not crucial for chaperone bind-
ing, a contributing role for clotting might be possible if ﬁbrin
formation itself is associated with the generation of cross-β
structures. Thiswas studiedbyclotting commerciallyavailable
puriﬁed ﬁbrinogen in calcium chloride with thrombin in the
presence of ThT. ►Fig. 5 shows that 3 mg/mL ﬁbrinogen
already produced a signiﬁcant ThT ﬂuorescence intensity of
approximately 4,000 a.u., which is in line with a positive ThT
signal produced by freshly isolated ﬁbrinogen from plasma
in ►Fig. 2. The ﬂuorescence intensity increased in time to
approximately 7,000 a.u. in the presence of thrombin, but did
not increase in the absence of thrombin (►Fig. 5A). The
increase in ﬂuorescence signal paralleled the increase in
turbidity associated with clot formation (►Fig. 5B), thus
providing evidence for the generation of cross-β structures
during ﬁbrin formation. The overall results indicate that the
clot binding of chaperone proteins could involve cross-β
structures originating from both unfolded ﬁbrinogen and
from the conversion of ﬁbrinogen into ﬁbrin.
A potential functional effect of clot binding of chaperone
proteins was studied with casein proteins, which have been
described as extracellular chaperonemolecules. The lag time of
plasma clot formation of approximately 12.6 minutes in-
creased dose-dependently to 26.0, 19.5, and 42.5 minutes in
the presence of 30 µM α-casein, β-casein, and κ-casein,
respectively.►Fig. 6 shows the clotting proﬁles in the presence
of κ-casein. The results thus indicated that the casein proteins
delayedﬁbrinpolymerizationduringclottingofdilutedplasma.
Discussion
This study shows that ﬁbrin clots generated from plasma are
decorated with the proteins which we identiﬁed as extracel-
lular chaperones. Extracellular chaperones bind to partially
unfoldedprotein structures. These structures are provided in a
ﬁbrin clot by small amounts of unfolded ﬁbrinogen in the
plasma. In addition, they are generated during the conversion
of ﬁbrinogen to ﬁbrin. The presence of extracellular
Fig. 4 Heat-induced formation of α1-antitrypsin (A1AT)–ﬁbrinogen
complex in plasma. Platelet-poor citrated plasma was stressed by
incubation at 37°C or 41°C for 0, 0.25, 1, or 2 days. After the
incubation ﬁbrinogen was isolated from the plasma samples by
ammonium sulfate precipitation. The amounts of A1AT–ﬁbrinogen
complex in the ﬁbrinogen samples were determined using an enzyme-
linked immunosorbent assay (ELISA). Mean values (  standard de-
viation [SD]) of ﬁve measurements are shown.
Fig. 5 Generation of cross-β structures during coagulation. (A) The
thioﬂavin T (ThT) ﬂuorescence of a solution containing ﬁbrinogen,
calcium chloride, and ThT, with (Fb) or without thrombin (Fbg) was
measured at the time points indicated. The background of the ThT
signal (2,759 arbitrary units [a.u.]) was subtracted from all samples.
(B) The turbidity of similar samples was measured as optical density
(OD) at 405 nm in parallel experiments. Mean (  standard deviation
[SD]) values are shown (n ¼ 3, in duplicate).
Fig. 6 Inhibition of ﬁbrin polymerization by κ-casein. Ninefold diluted
plasma was clotted with thrombin and calcium chloride in the
presence of 0–30 µM κ-casein. Fibrin polymerization was visualized by
measuring the turbidity as optical density (OD) at 405 nm at room
temperature.
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chaperones inclotsandthrombi is anew featurewithpotential
implications for thrombotic diseases and bleeding disorders.
Extracellular Chaperones
In a previous study, we described that extensively washed
plasma clots contain many noncovalently bound plasma
proteins and we identiﬁed the most abundant ones by
mass spectrometry.8 These proteins included several hemo-
static proteins. However, the majority of the proteins had no
known hemostatic function and the cause of the presence of
these proteins remained unclear. We noted the presence of
several proteins originating from high-density lipoproteins
and postulated that these lipoproteins may play a role in
hemostasis. Up to now, no information is available about the
binding of high-density lipoproteins to ﬁbrin clots. The main
discovery of the present study is that most of the apparently
nonhemostatic proteins noncovalently bound to ﬁbrin clots
are described in the literature as extracellular chaperones.12
Molecular chaperones interact with other proteins to
stabilize them or to help them acquire their functionally
active conformation, without being present in its ﬁnal struc-
ture.18 Intracellular chaperones have been known for a long
time and many of them are heat shock proteins. Knowledge
of extracellular chaperones has laggedwell behind. However,
in recent years it has become clear that there is a family of
abundant proteins in the extracellular ﬂuids that share
functional characteristics with the intracellular small heat
shock proteins. They bind to unfolded proteins in the extra-
cellular ﬂuids, inhibit their aggregation, and promote clear-
ance from extracellular spaces.12 Therefore, theymayprotect
us from diseases that are characterized by extracellular
protein deposition such as Alzheimer’s disease, prion dis-
eases, macular degeneration, and type 2 diabetes. The main
chaperones involved in these diseases and actually colocal-
ized in the protein deposits are clusterin, haptoglobin, and
α2M.12
After the discovery in the present study that most of the
apparently nonhemostatic proteins in ﬁbrin clots are extra-
cellular chaperones, we next investigated whether they are
localized in the clots as a result of their chaperone activities.
Heat is awell-known inducer of protein unfolding and cross-
β structures in the laboratory. It thermally destabilizes the
tertiary and secondary protein structure leading to protein
unfolding and aggregation and mimics the prolonged effects
of aging and shear stress on plasma proteins. Heat-induced
unfolding of extracellular proteins thus differs from intracel-
lular unfolding/misfolding during protein maturation.12 We
ﬁrst tested which temperature is required to induce an
increase of cross-β structures in ﬁbrinogen and found that
incubation of plasma for 2 days at 41°C resulted in a signiﬁ-
cant increase of these structures (►Fig. 2). We then found
that these conditions indeed generated a strong increase in
the amount of clot-bound proteins (►Fig. 3).
It should be noted that the majority but not all of the clot-
bound proteins have been described as chaperones. One
explanation is that the nonchaperone proteins might be
incorporated into ﬁbrin clots as a constituent of a larger
particle containing a strong chaperone, such as a clusterin-
containing high-density lipoprotein particle. The presence of
apoAIV could be explained in this manner.
Our ﬁnding that certain proteinswith reported but not yet
conﬁrmed chaperone-like activity are present in ﬁbrin clots,
provides additional evidence that they can be classiﬁed as
extracellular chaperones. One example is A1AT. Although its
chaperone identity has still to be proven,12 A1AT is the most
abundant and remarkably strongly bound plasma protein in
a ﬁbrin clot.14
It is known that the hemostatic proteins tPA and plasmino-
gen bind to ﬁbrin. Because tPA is present in plasma at low
concentrations (ng/mL range), this proteinwas not detected in
our proteomic studies, but it is well known that tPA, and
possibly also plasminogen, interacts with denatured pro-
teins.19,20 tPA has been characterized as a multiligand cross-
β structure receptor.21 Its binding to amyloidﬁbrils isnot solely
dependent on theﬁngerdomain or on the lysinebinding site in
kringle 2 domain, but involves multiple domains of tPA.22 The
plasminogenactivatormayplaya role in the removal of cross-β
structure-containing (improperly folded)proteinsviaplasmin-
mediated proteolysis. Thus, tPA shares functional properties
with extracellular chaperones by promoting clearance of un-
folded proteins from extracellular spaces. The plasminogen
activation system may work synergistically with other chap-
erones such as clusterin and α2M, which are involved in the
neutralization and clearance of soluble and potentially cyto-
toxic fragments of protein aggregates.23
It is interesting that a 420-kDa isoform of ﬁbrinogen
(ﬁbrinogen-420), but not the predominant 340 kDa form,
shows chaperone-like activity.24 This holds true, in particu-
lar, for the additional 236-residue carboxyl terminus globu-
lar domain of ﬁbrinogen-420 (αEC) in isolated form, which
might be produced in vivo by proteolysis of ﬁbrinogen-420.
However, the plasma concentrations of ﬁbrinogen-420 (1%
of the total ﬁbrinogen concentration) and its degradation
product αEC (a small fraction of ﬁbrinogen-420) are low,
much lower than the plasma concentrations of the known
extracellular chaperones and they were therefore not
detected in the present study.
Cross-β Structures
What is the origin of cross-β structures in ﬁbrin clots? Our
experiments with heat-stressed plasma indicate that unfold-
ed ﬁbrinogen is involved in protein binding to clots from this
plasma and suggest that in untreated plasma unfolded
ﬁbrinogen could also play a role. Indeed, ﬁbrinogen from
unheated plasma showed already signiﬁcant ThT ﬂuores-
cence (►Fig. 2). Although this ﬂuorescence could, in theory,
be ascribed to some nonspeciﬁc binding of ThT,17 the pres-
ence of real cross-β structures is supported by the presence
of A1AT–ﬁbrinogen complexes in unheated plasma (►Fig. 4).
These observations could possibly be explained by in vitro
handling of blood and plasma. However, unfolded ﬁbrinogen
may already occur in the circulation. The in vivo half-life of
ﬁbrinogen is approximately 4 days. Although ►Fig. 4 shows
that during incubation of plasma for 2 days at 37°C no
signiﬁcant amounts of A1AT–ﬁbrinogen complexes are gen-
erated, additional experiments reveal that detectable
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amounts are generated during incubation for 4 days at 37°C
(data not shown). Moreover, additional stress factors are
present in the circulation such as shear and oxidation. It has
been shown that shear stress induces the formation of
clusterin–ﬁbrinogen complexes in plasma25 and that oxida-
tion induces the formation of α2M–ﬁbrinogen complexes.26
In this connection, it is interesting to note that ﬁbrinogen is
much more susceptible to oxidative modiﬁcation than other
major plasma proteins.27
In addition to unfolded ﬁbrinogen in plasma, ﬁbrin
formation itself might be associated with the generation
of cross-β structures. This was presented in an interesting
review article by Gebbink,28 but experimental details are
missing. Longstaff et al29 observed cross-β structures pre-
dominantly in ﬁbrin agglomerates that arise on the surface
of a clot during external lysis.30 Other investigators collect-
ed evidence that coagulation is normally not associated
with β-sheet formation, but that clotting of plasma from
patients with various inﬂammatory diseases clearly results
in ﬁbrin with amyloid properties.31,32 Because of these
different results and views, we studied this topic in detail
and clotted puriﬁed ﬁbrinogen in the presence of ThT
(►Fig. 5). A generation of cross-β structures was observed
in parallel with the formation of a ﬁbrin network, detected
as turbidity. This is in line with the original observations by
Hudry-Clergeon et al33 that (cross-) β sheet structures
increased signiﬁcantly from approximately 10% in ﬁbrino-
gen to 20% in ﬁne clots with thin ﬁbers or 30% in coarse
clots with thick ﬁbers. The difference between ﬁne and
coarse clot observed by these authors indicates that the
cross-β structures depend on the lateral aggregation of
protoﬁbrils.33 More recent work indeed suggests that poly-
merization of αC domains of ﬁbrin involves the formation of
β-sheets.34 Taken together, the data supports the notion
that normal ﬁbrin formation is associated with the forma-
tion of cross-β structures.28 This does not exclude the
possibility that additional cross-β structures could be
formed during thrombus formation under inﬂammatory
conditions31,32 or during external lysis of thrombi.29 Of
interest is that deformation of ﬁbrin clots during stretching
or compression is associated with a α-helix to β-sheet
transition and formation of cross-β structures.35 This tran-
sition occurs in the coiled-coil regions of a ﬁbrin molecule.
The binding sites in a ﬁbrin clot for chaperone proteins
could be provided by both unfolded ﬁbrinogen and struc-
tures generated during ﬁbrin formation. In terms of ThT
ﬂuorescence intensity under the experimental conditions
of ►Fig. 5, the respective contributions are approximately
4,000 and 3,000 a.u., which means of the same order of
magnitude. It is, however, still uncertain whether the two
types of cross-β structures are similarly involved in chaper-
one binding. Until now, we (in ►Fig. 4) and others25,26 have
only proven that unfolded ﬁbrinogen in plasma does bind
extracellular chaperones.
Potential Implications
This study explains the strong binding of several plasma
proteins to ﬁbrin clots by their identiﬁcation as extracellular
chaperones. The amounts of the bound chaperones are sub-
stoichiometric with respect to ﬁbrin. For instance, we previ-
ously estimated that the amount of A1AT bound to normal
ﬁbrin clots was 0.25 μg A1AT per mg of ﬁbrin,14 which
corresponds to a molar ratio of 1:700. The molar ratio of all
bound chaperones together will, however, be several times
greater. In addition, the stoichiometry might increase in dis-
easeswithelevatedconcentrationsofextracellular chaperones
in the circulation or elevated contents of cross-β structures in
clots. Although the amounts of clot-boundchaperones are low,
theyare of thesameorder ofmagnitude as theamounts ofclot-
bound hemostatic proteins with a regulatory effect such as
plasminogen, FXIII-A, and thrombin (►Fig. 1), suggesting that
the chaperones could possibly also play a regulatory role in
thrombosis andhemostasis. Potentialmechanisms include the
inhibition of ﬁbrin polymerization and the promotion of the
clearance of unfolded ﬁbrin(ogen) from the circulation. We
tested the antipolymerizing effect of casein proteins, readily
available proteins that have been recognized as extracellular
chaperones. These proteins include α-casein36,37 as well as β-
casein and κ-casein.38 All casein proteins proved to inhibit
ﬁbrin polymerization by signiﬁcantly increasing the lag time
of clot formation (►Fig. 6). Future studies should show how
effective the extracellular chaperones from plasma inhibit
ﬁbrin polymerization and reveal anticoagulant activity. It is
interesting that extracellular chaperones, such ashigh-density
lipoprotein and its major ApoAI, might also be antithrombotic
by preventing von Willebrand factor self-association and
subsequent platelet adhesion.39
What is known about this topic?
• Plasma clots contain many ﬁbrin-bound proteins.
• Fibrin-bound proteins include several hemostatic pro-
teins, but also apparently nonhemostatic proteins.
What does this paper add?
• The most abundant ﬁbrin-binding proteins are identi-
ﬁed as extracellular chaperones. Extracellular chaper-
ones usually bind to partially unfolded proteins, which
may form cross-β (amyloid-like) structures.
• Cross-β (amyloid-like) structures in ﬁbrin clots origi-
nate both from misfolded/unfolded ﬁbrinogen in plas-
ma and from ﬁbrin formation.
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